We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals

hedge funds and large institutions have $2.79M invested in Tonix Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

84% less capital invested

Capital invested by funds: $17.4M → $2.79M (-$14.6M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $116K

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$116K
Net Calls
-$116K
Net Calls Change
-$21K
Name Holding Trade Value Shares
Change
Change in
Stake
FO
26
FT Options
Illinois
$10K
TC
27
TFS Capital
Pennsylvania
$10K
KA
28
Klingman & Associates
New York
$7K
BIM
29
BlackRock Investment Management
Delaware
$3K
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$3K
Wells Fargo
31
Wells Fargo
California
$2K
BA
32
BlackRock Advisors
Delaware
$1K
Creative Planning
33
Creative Planning
Kansas
$1K
Manulife (Manufacturers Life Insurance)
34
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K
Bank of America
35
Bank of America
North Carolina
-$10K
BC
36
Broadfin Capital
New York
-$863K
CB
37
Community Bank
New York
-$3K
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
-$169K
First Manhattan
39
First Manhattan
New York
-$5K
FMA
40
FNY Managed Accounts
New York
-$51.7K
Franklin Resources
41
Franklin Resources
California
-$3.2M
JP Morgan Chase
42
JP Morgan Chase
New York
-$27K
OM
43
Opaleye Management
Massachusetts
-$1.59M
OAM
44
Oxford Asset Management
United Kingdom
-$76K
PVI
45
Pura Vida Investments
New York
-$567K
Stifel Financial
46
Stifel Financial
Missouri
-$30K
TRCT
47
Tower Research Capital (TRC)
New York
-$1K
UBS Group
48
UBS Group
Switzerland
-$21K